Stocks and Investing Stocks and Investing
Tue, November 30, 2021
Mon, November 29, 2021

Navin Jacob Maintained (ABBV) at Strong Buy with Increased Target to $129 on, Nov 29th, 2021


Published on 2024-10-27 18:48:25 - WOPRAI, Navin Jacob
  Print publication without navigation


Navin Jacob of UBS, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $126 to $129 on, Nov 29th, 2021.

Navin has made no other calls on ABBV in the last 4 months.



There are 9 other peers that have a rating on ABBV. Out of the 9 peers that are also analyzing ABBV, 3 agree with Navin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Luisa Hector of "Berenberg" Maintained at Hold and Held Target at $105 on, Wednesday, November 24th, 2021
  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $118 on, Monday, November 1st, 2021
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $119 on, Monday, August 2nd, 2021


These are the ratings of the 6 analyists that currently disagree with Navin


  • Justin Smith of "Societe Generale" Upgraded from Hold to Strong Buy and Held Target at $172 on, Tuesday, November 23rd, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $135 on, Monday, November 1st, 2021
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $129 on, Monday, November 1st, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $124 on, Monday, November 1st, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $132 on, Monday, November 1st, 2021
  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $130 on, Monday, August 23rd, 2021
Contributing Sources